Intent to Revise Announcement

• Six–Month Implementation Guide (2008) (07/02/08)
• USP Announces a Revised Monograph For Levothyroxine Sodium Tablets (08/29/08)
• USP to Defer Decision on Green Tea Extract Cautionary Labeling  (49KB) (07/02/08)
• General Chapter <643> Total Organic Carbon Comment Period Extension (10/17/07)
• USP Statement on Prednisone Tablets: Notice of Change in Performance (10/10/07)
• Updated range for USP Prednisone Tablets Reference Standard  (123KB) (07/16/07)
• Explanatory note regarding USP–NF General Chapter <467> Residual Solvents / Organic Volatile Impurities (06/15/07)
• Explanatory Note regarding Revisions to General Chapter <1121> (06/04/07)
• USP–NF General Chapter <905> Uniformity of Dosage Units (04/20/07)
• Delayed Implementation for General Chapter <467> Residual Solvents (06/15/07)
• USP Statement <729> Globule Size Distribution in Lipid Injection Emulsions (02/15/07)
• The USP Performance Test and the Dissolution Procedure Statement (10/24/06)
• Recent Modifications to the USP Standards–Setting Process (07/17/06)
• The USP Performance Test: Mechanical Calibration vs. a Periodic Performance Verification Test with Chemical Tablets (Calibrators) (06/17/06)
• Coordination of PF Submissions and New USP Reference Standards (04/03/06)
• Coordination of Official New Monographs, Revisions, and USP Reference Standards (02/20/06)
• USP Releases Improved Packaging for Salicylic Acid Calibrator Tablets (10/19/05)
• Notice of Revision to General Chapter Heavy Metals <231> Method II (06/14/05)